Cannabis Sativa Inc (OTCMKTS:CBDS) insider David Tobias sold 8,000 shares of the business’s stock in a transaction that occurred on Friday, June 16th. The stock was sold at an average price of $4.09, for a total transaction of $32,720.00. Following the completion of the sale, the insider now owns 4,292,542 shares in the company, valued at $17,556,496.78. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

David Tobias also recently made the following trade(s):

  • On Thursday, June 8th, David Tobias sold 5,000 shares of Cannabis Sativa stock. The stock was sold at an average price of $4.00, for a total transaction of $20,000.00.
  • On Wednesday, March 29th, David Tobias sold 19,190 shares of Cannabis Sativa stock. The stock was sold at an average price of $6.54, for a total transaction of $125,502.60.
  • On Monday, March 27th, David Tobias sold 4,659 shares of Cannabis Sativa stock. The stock was sold at an average price of $6.25, for a total transaction of $29,118.75.

Cannabis Sativa Inc (OTCMKTS CBDS) traded up 10.85% during mid-day trading on Monday, hitting $4.70. 140,182 shares of the company were exchanged. The stock’s market cap is $91.08 million. Cannabis Sativa Inc has a 12-month low of $1.52 and a 12-month high of $9.50. The company has a 50 day moving average of $5.14 and a 200 day moving average of $5.84.

Insider Buying and Selling by Quarter for Cannabis Sativa (OTCMKTS:CBDS)

COPYRIGHT VIOLATION WARNING: This news story was reported by American Banking News and is the sole property of of American Banking News. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of international copyright laws. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/06/19/david-tobias-sells-8000-shares-of-cannabis-sativa-inc-cbds-stock.html.

About Cannabis Sativa

Cannabis Sativa, Inc develops and promotes natural cannabis products. The Company is engaged in the research, development and licensing of natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems. The Company plans to develop, produce and market products through joint ventures with companies licensed under state regulations applicable to cannabis businesses.

Receive News & Ratings for Cannabis Sativa Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannabis Sativa Inc and related companies with MarketBeat.com's FREE daily email newsletter.